Search

Search bills, members, committees and pages...

PARI MODY

24 federal lobbying filings, 2023 to 2026.

PARI MODY is a registered lobbyist named on 24 federal lobbying filings, 2023 to 2026, reporting $1.9M across them.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

1 they have filed under, by filings.

RegistrantFilingsReported
ARNOLD & PORTER KAYE SCHOLER LLP24$1.9M

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20264$920K
20254$240K
20245$240K
202311$540K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues24
MMMMedicare/Medicaid19
TAXTaxation/Internal Revenue Code12
BUDBudget/Appropriations3
CPTCopyright/Patent/Trademark2

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 3731Small Biotech Innovation Act5
S. 1930Small Biotech Innovation Act5
S. 5029Educators for America Act1

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
EXELIXIS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2026 second_quarter$60KJul 20, 2026
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)ARNOLD & PORTER KAYE SCHOLER LLP2026 second_quarter$380KJul 17, 2026
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)ARNOLD & PORTER KAYE SCHOLER LLP2026 first_quarter$420KApr 20, 2026
EXELIXIS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2026 first_quarter$60KApr 20, 2026
EXELIXIS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2025 fourth_quarter$60KJan 16, 2026
EXELIXIS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2025 third_quarter$60KOct 16, 2025
EXELIXIS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2025 second_quarter$60KJul 17, 2025
EXELIXIS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2025 first_quarter$60KApr 18, 2025
EXELIXIS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2024 fourth_quarter$60KJan 17, 2025
EXELIXIS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2024 third_quarter$60KOct 18, 2024
EXELIXIS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2024 second_quarter$60KJul 18, 2024
EXELIXIS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2024 first_quarter$60KApr 22, 2024
ADAPTIVE BIOTECHNOLOGIESARNOLD & PORTER KAYE SCHOLER LLP2023 fourth_quarter$30KJan 20, 2024
EXELIXIS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2023 fourth_quarter$60KJan 19, 2024
EXELIXIS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2024 first_quarterJan 19, 2024
EXELIXIS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2023 fourth_quarter$60KJan 18, 2024
ADAPTIVE BIOTECHNOLOGIESARNOLD & PORTER KAYE SCHOLER LLP2023 third_quarter$30KOct 16, 2023
EXELIXIS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2023 third_quarter$60KOct 13, 2023
PROVENTION BIO, INC.ARNOLD & PORTER KAYE SCHOLER LLP2023 second_quarter$20KJul 19, 2023
ADAPTIVE BIOTECHNOLOGIESARNOLD & PORTER KAYE SCHOLER LLP2023 second_quarter$60KJul 18, 2023
EXELIXIS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2023 second_quarter$60KJul 18, 2023
PROVENTION BIO, INC.ARNOLD & PORTER KAYE SCHOLER LLP2023 first_quarter$20KApr 14, 2023
EXELIXIS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2023 first_quarter$60KApr 13, 2023
ADAPTIVE BIOTECHNOLOGIESARNOLD & PORTER KAYE SCHOLER LLP2023 first_quarter$80KApr 13, 2023